Serina Therapeutics is located at the HudsonAlpha Institute for Biotechnology
Serina Therapeutics, Inc.
601 Genome Way
Huntsville, Alabama 35806
Phone | 256.327.0566
In 1987, Mr. Hudson founded Research Genetics in Huntsville, Alabama. He served as chief executive until 2000 when the company was acquired by Invitrogen (now Life Technologies, Inc.) in a deal valued at $138 million. Prior to the merger, Research Genetics had become the world’s leader in genetic linkage products and an integral partner in the Human Genome Project coordinated by the U.S. Department of Energy and the National Institutes of Health. Mr. Hudson has advised and incubated multiple companies in industries ranging from internet services to genetics research.
Currently, Mr. Hudson serves as co-chairman of the board of directors of the HudsonAlpha Institute for Biotechnology, a nonprofit research institute founded in Huntsville with a mission to use biotechnology to improve human health, stimulate economic development and inspire Alabama’s youth to seek careers in science. He also serves as vice president of CityScapes LLC, a company focused on downtown revitalization projects, particularly those appealing to young professionals.